Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-04-12, Stock:ABBV, The news for the past five days is as follows:
2021-04-05: NEWS1: AbbVie's (ABBV) Rinvoq Dermatitis sNDA Review Gets Delayed.
2021-04-06: NEWS1: Should You Buy AbbVie in April?.
2021-04-07: NEWS1: 3 Large-Cap Stocks to Buy and Hold to Start Q2.NEWS2: Pfizer’s Xeljanz Faces Canadian Review Amid More Scrutiny of JAK Inhibitors.NEWS3: Barron’s Stock Screen: The 5 ‘Dividend Aristocrats’ With the Fastest-Growing Payouts.NEWS4: AbbVie Submits Regulatory Applications for SKYRIZI® (risankizumab) in Psoriatic Arthritis to FDA and EMA.NEWS5: AbbVie to Present Data Across its Robust Neuroscience Portfolio at the 2021 American Academy of Neurology (AAN) Annual Meeting.NEWS6: Not All Dividend Aristocrats Are the Same. Here Are 5 With Fast-Growing Payouts.
2021-04-08: NEWS1: AbbVie (ABBV) Seeks Skyrizi Approval for Psoriatic Arthritis.NEWS2: Is It Time To Buy AbbVie Stock — Or Will Pfizer's Bad News Continue To Hurt?.
2021-04-09: NEWS1: Pharma Stock Roundup: FDA Decision Delays for PFE, LLY, ABBV, AZN Vaccine Woes.NEWS2: The Zacks Analyst Blog Highlights: ServiceNow, AbbVie and Apple.NEWS3: Don't Race Out To Buy AbbVie Inc. (NYSE:ABBV) Just Because It's Going Ex-Dividend.

Answer: Rise